China Resources Boya Bio-pharmaceutical Group Co., Ltd. engages in the blood products, diabetes medication, biochemical medication, and chemical medicine businesses in China. It engages in the research and development, production, and sales of blood products comprising human fibrinogen, intravenous human immunoglobulin, rabies immunoglobulin, human albumin, human immunoglobulin, freeze-dried intravenous human immunoglobulin, and hepatitis B human immunoglobulin; diabetes products, including metformin hydrochloride tablets/enteric-coated tablets, pioglitazone hydrochloride dispersible tablets, glimepiride tablets, and calcium dobesilate capsules; and compound osteotide, oxytocin, and heparin sodium injections for various fields, such as medicine, hepatitis, gynecology, and immunomodulation. The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co., Ltd. China Resources Boya Bio-pharmaceutical Group Co., Ltd. was founded in 1993 and is based in Fuzhou, China.
China Resources Boya Bio-pharmaceutical Dividend Announcement
• China Resources Boya Bio-pharmaceutical announced a semi annually dividend of ¥0.16 per ordinary share which will be made payable on 2024-10-25. Ex dividend date: 2024-10-25
• China Resources Boya Bio-pharmaceutical annual dividend for 2024 was ¥0.46
• China Resources Boya Bio-pharmaceutical annual dividend for 2023 was ¥0.20
• China Resources Boya Bio-pharmaceutical's trailing twelve-month (TTM) dividend yield is 1.49%
• China Resources Boya Bio-pharmaceutical's payout ratio for the trailing twelve months (TTM) is 81.29%
• China Resources Boya Bio-pharmaceutical's dividend growth over the last five years (2018-2023) was 5.92% year
• China Resources Boya Bio-pharmaceutical's dividend growth over the last ten years (2013-2023) was -8.76% year
China Resources Boya Bio-pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-10-25 | ¥0.16 | semi annually | 2024-10-25 |
2024-04-26 | ¥0.30 | semi annually | 2024-04-26 |
2023-04-28 | ¥0.20 | semi annually | 2023-04-28 |
2022-05-13 | ¥0.15 | semi annually | 2022-05-13 |
2021-05-26 | ¥0.07 | semi annually | 2021-05-26 |
2020-06-19 | ¥0.15 | semi annually | 2020-06-19 |
2019-06-26 | ¥0.15 | semi annually | 2019-06-26 |
2018-07-11 | ¥0.15 | semi annually | 2018-07-11 |
2017-05-26 | ¥0.10 | semi annually | 2017-05-26 |
2016-05-13 | ¥0.20 | semi annually | |
2015-04-07 | ¥0.60 | semi annually | |
2014-04-03 | ¥0.50 | semi annually | |
2013-03-20 | ¥0.50 | semi annually |
China Resources Boya Bio-pharmaceutical Dividend per year
China Resources Boya Bio-pharmaceutical Dividend growth
China Resources Boya Bio-pharmaceutical Dividend Yield
China Resources Boya Bio-pharmaceutical current trailing twelve-month (TTM) dividend yield is 1.49%. Interested in purchasing China Resources Boya Bio-pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
China Resources Boya Bio-pharmaceutical Financial Ratios
China Resources Boya Bio-pharmaceutical Dividend FAQ
Other factors to consider when evaluating China Resources Boya Bio-pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy China Resources Boya Bio-pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: China Resources Boya Bio-pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, China Resources Boya Bio-pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, China Resources Boya Bio-pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from China Resources Boya Bio-pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: China Resources Boya Bio-pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, China Resources Boya Bio-pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: China Resources Boya Bio-pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of China Resources Boya Bio-pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review China Resources Boya Bio-pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.